The S&P 500 has dropped 3.8% since the end of July, but that's nothing compared to the losses we've seen from biotech stocks.
In fact, this week's latest pullback has many biotech stocks in bear market territory.
Featured Story
Biotech Stocks Have Now Reached Bear Market Territory 
The S&P 500 has dropped 3.8% since the end of July, but that's nothing compared to the losses we've seen from biotech stocks.
In fact, this week's latest pullback has many biotech stocks in bear market territory.
The S&P 500 has dropped 3.8% since the end of July, but that's nothing compared to the losses we've seen from biotech stocks.
In fact, this week's latest pullback has many biotech stocks in bear market territory.
